Jesse Shefferman - 26 Jan 2026 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Jesse Shefferman
Issuer symbol
TARA
Transactions as of
26 Jan 2026
Net transactions value
-$58,242
Form type
4
Filing time
27 Jan 2026, 16:10:07 UTC
Previous filing
22 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shefferman Jesse CEO and President, Director C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK /s/ Jesse Shefferman 27 Jan 2026 0001799167

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $58,242 -8,732 -0.85% $6.67 1,021,832 26 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025.